CELL AND GENE THERAPY INSIGHTS

Volume 9 Issue 6

Cell and Gene Therapy Insights Volume 9 Issue 6

Download PDF

Featuring

Issue Spotlight: Gene therapy CMC & analytics
Webinars

Gene therapy CMC & analytics

Guest Editor:

Lauren Drouin, Director, Analytical Development at Alexion, AstraZeneca Rare Disease

Interview

Assessing the AAV analytic toolkit: considerations for application & regulatory compliance

Assessing the AAV analytic toolkit: considerations for application & regulatory compliance

Juliette Reviron

3 May 2023

Read

Accelerating your gene therapy to patients: not all platforms are created equal

Accelerating your gene therapy to patients: not all platforms are created equal

George Buchman, Thomas VanCott

22 June 2023

Watch

Addressing regulatory guidance for HEK293 cells and AAV-based therapeutic manufacturing

Addressing regulatory guidance for HEK293 cells and AAV-based therapeutic manufacturing

Michael Brewer

29 June 2023

Watch

Overcoming challenges in scaled manufacturing of iPSC-derived cells

Overcoming challenges in scaled manufacturing of iPSC-derived cells

A Steinbach, D Mann, M Diakatou et al.

6 July 2023

Watch

Early-stage considerations for accelerating cell and gene therapy commercialization

Early-stage considerations for accelerating cell and gene therapy commercialization

Sabrina Carmichael

11 July 2023

Watch

Aldevron case study: validation of mRNA concentration determination using variable pathlength spectroscopy

Aldevron case study: validation of mRNA concentration determination using variable pathlength spectroscopy

J Ferraiolo, T Alvine, J Long

12 July 2023

Watch

Regulatory considerations and validation strategies for mycoplasma testing for cell-based therapies

Regulatory considerations and validation strategies for mycoplasma testing for cell-based therapies

Michael Brewer

20 July 2023

Watch

Exploring and overcoming the challenges of cell and gene-modified cell therapy CMC

Exploring and overcoming the challenges of cell and gene-modified cell therapy CMC

J Sable, L Bellot, K Doucette

25 July 2023

Watch

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Utilizing an automation-on-demand analytical tool for cancer immunotherapy

Christoph Eberle

26 July 2023

Watch

Three distinct analytical ultracentrifugation methods for virus and viral vector characterizations

Three distinct analytical ultracentrifugation methods for virus and viral vector characterizations

Susumu Uchiyama

27 July 2023

Watch

Expanding access to gene therapies through novel cell lines and dPCR technologies

Expanding access to gene therapies through novel cell lines and dPCR technologies

J Loganathan, A Noyszewski, M Voigt

1 August 2023

Watch

AAV and lentiviral titer determination - past, present, and future

AAV and lentiviral titer determination - past, present, and future

J Bechill, P Wang, M White

10 August 2023

Watch

Harnessing mass photometry for AAV sample characterization in GMP-regulated environments

Harnessing mass photometry for AAV sample characterization in GMP-regulated environments

Cátia Crespo

15 August 2023

Watch

Accelerating analysis of viral vector titer, process impurities, and contaminants

Accelerating analysis of viral vector titer, process impurities, and contaminants

J Chappell, J Norton, I Osorio Querejeta et al.

6 September 2023

Watch

Strategies to accelerate AAV chromatography process development

Strategies to accelerate AAV chromatography process development

Kelley Kearns

12 September 2023

Watch

Pushing the boundaries of LNP production: an innovative analytical platform for evaluating vital LNP characteristics

Pushing the boundaries of LNP production: an innovative analytical platform for evaluating vital LNP characteristics

Nejc Pavlin

26 September 2023

Watch